Baltimore, Maryland.
Trans Am Clin Climatol Assoc. 2024;134:149-164.
Early in the pandemic, clinicians recognized an overlap between Long COVID symptoms and dysautonomia, suggesting autonomic nervous system (ANS) dysfunction. Our clinical experience at Johns Hopkins with primary dysautonomia suggested heritability of sympathetic dysfunction, manifesting primarily as hyperhidrosis and as other dysautonomia symptoms. Whole exome sequencing revealed mutations in genes regulating electrical signaling in the nervous system, thus providing a genetic basis for the sympathetic overdrive observed. We hypothesize that dysautonomia in Long COVID requires two molecular hits: a genetic vulnerability to prime the ANS and a SARS-CoV-2 infection, as an immune trigger, to further disrupt ANS function resulting in increased sympathetic activity. Indeed, Long COVID patients show signs of chronic inflammation and autoimmunity. We have translated this two-hit concept to the clinic using ion channel inhibitors to target genetic susceptibility and immunomodulators to treat inflammation. This multi-hit hypothesis shows promise for managing Long COVID and merits further study.
在疫情早期,临床医生就发现新冠长期症状与自主神经功能紊乱之间存在重叠,这表明自主神经系统(ANS)功能障碍。我们在约翰霍普金斯大学对原发性自主神经功能紊乱的临床经验表明,交感神经功能障碍具有遗传性,主要表现为多汗症和其他自主神经功能紊乱症状。全外显子组测序显示,调节神经系统电信号的基因发生突变,从而为观察到的交感神经兴奋提供了遗传基础。我们假设新冠长期症状中的自主神经功能紊乱需要两个分子打击:一是 ANS 的遗传易感性,二是 SARS-CoV-2 感染作为免疫触发因素,进一步破坏 ANS 功能,导致交感神经活动增加。事实上,新冠长期症状患者表现出慢性炎症和自身免疫的迹象。我们已经将这一“双打击”概念应用于临床,使用离子通道抑制剂来针对遗传易感性,免疫调节剂来治疗炎症。这一多打击假说为管理新冠长期症状提供了希望,值得进一步研究。